Learn About A Treatment Option For Hepatitis C

Important Safety Information | Important Facts

THIS CONTENT IS FROM OUR SPONSOR:

LEARN ABOUT A
TREATMENT OPTION
FOR HEPATITIS C

HOME

For Adults with Chronic Hepatitis C Genotypes 1-6,

EPCLUSA COULD BE
YOUR KIND OF CURE

Only one pill, once a day taken with or without food.

EPCLUSA has an overall cure rate of 98% across all 6 main types of hepatitis C.*^†‡ Most people take just one pill, once a day for 12 weeks, with or without food.^§ Talk to your Hepatitis C Specialist today.

Cure means the hepatitis C virus is not detected in the blood when measured three months after treatment is completed.

EPCLUSA is highly effective across all 6 main hepatitis C genotypes

98 percent overall cure rate for hepatitis C treatment

All 1 2 3 4 5 6

* In a study of 740 patients with genotype 1, 2, 4, 5, or 6 hepatitis C, with or without prior hepatitis C treatment, and with or without cirrhosis (compensated), who received either EPCLUSA or placebo for 12 weeks, 98% (323 out of 328) of patients with genotype 1, 100% (116 out of 116) of patients with genotype 4, 97% (34 out of 35) of patients with genotype 5, and 100% (41 out of 41) of patients with genotype 6, who received EPCLUSA once daily for 12 weeks were cured.

^† In a study of 266 patients with genotype 2 hepatitis C, with or without prior hepatitis C treatment, and with or without cirrhosis (compensated), who received either EPCLUSA or sofosbuvir + ribavirin for 12 weeks, 99% (133 out of 134) of patients who received EPCLUSA once daily for 12 weeks were cured.

^‡ In a study of 552 patients with genotype 3 hepatitis C, with or without prior hepatitis C treatment, and with or without cirrhosis (compensated), who received either EPCLUSA for 12 weeks or sofosbuvir + ribavirin for 24 weeks, 95% (264 out of 277) of patients who received EPCLUSA once daily for 12 weeks were cured. Cure rates for EPCLUSA ranged from 89% (with prior hepatitis C treatment and with cirrhosis) to 98% (without prior hepatitis C treatment and without cirrhosis).

These studies did not include patients with advanced cirrhosis (decompensated).^||

^§ EPCLUSA with ribavirin is recommended for patients with advanced cirrhosis (decompensated).^|| If you take EPCLUSA with ribavirin, you should also read the ribavirin Medication Guide for important pregnancy-related information.

^|| Advanced cirrhosis (decompensated) is when the liver is extensively scarred and can no longer do its job effectively.

To learn about the common side effects of EPCLUSA, click here.

How soon can I expect to see results?

Use the calculator below to see when you can find out whether you've been cured with EPCLUSA. Cure means the hepatitis C virus is not detected in the blood when measured three months after treatment is completed.

EPCLUSA requires just 12 weeks of treatment (for most people, only one pill, once a day). Your doctor will test you three months after your last pill.

START DATE

END DATE

TEST RESULTS

FIND OUT

Watch Chris' story about curing his hepatitis C with EPCLUSA.

UP NEXT

Questions about insurance converage, savings, & support?

Cost shouldn't be a barrier to treatment: find out about the savings options available for EPCLUSA.

Learn more about the disease and the importance of treating hepatitis C.

FIND OUT MORE AT EPCLUSA.COM

FIND A HEPATITIS C
SPECIALIST:

Check your eligibility for EPCLUSA savings

ELIGIBLE PEOPLE MAY PAY AS
LITTLE AS $5 PER CO-PAY.

Restrictions apply.

FIND OUT MORE

Important Safety Information

What is the most important information I should know about EPCLUSA?

EPCLUSA can cause serious side effects, including:

Hepatitis B virus reactivation: Before starting EPCLUSA treatment, your healthcare provider will do blood tests to check for hepatitis B infection. If you have ever had hepatitis B, the hepatitis B virus could become active again during and after treatment with EPCLUSA. This may cause serious liver problems including liver failure and death. If you are at risk, your healthcare provider will monitor you during and after taking EPCLUSA.

Continued Below

Important Safety Information

What is the most important information I should know about EPCLUSA?

EPCLUSA can cause serious side effects, including:

Hepatitis B virus reactivation: Before starting EPCLUSA treatment, your healthcare provider will do blood tests to check for hepatitis B infection. If you have ever had hepatitis B, the hepatitis B virus could become active again during and after treatment with EPCLUSA. This may cause serious liver problems including liver failure and death. If you are at risk, your healthcare provider will monitor you during and after taking EPCLUSA.

What should I tell my healthcare provider before taking EPCLUSA?

Tell your healthcare provider about all of your medical conditions, including if you have ever had hepatitis B infection or liver problems other than hepatitis C infection; if you have severe kidney problems or are on dialysis; if you have HIV; or if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed. It is not known if EPCLUSA will harm your unborn baby or pass into your breast milk. If you take EPCLUSA with ribavirin, you should also read the ribavirin Medication Guide for important pregnancy-related information.
Tell your healthcare provider and pharmacist about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. EPCLUSA and certain other medicines may affect each other, or may cause side effects.

What are the possible side effects of EPCLUSA?

Serious side effects may also include:

Slow heart rate (bradycardia): EPCLUSA, when taken with amiodarone (Cordarone^®, Nexterone^®, Pacerone^®), a medicine used to treat certain heart problems, may cause slow heart rate. In some cases slow heart rate has led to death or the need for a pacemaker when amiodarone is taken with medicines containing sofosbuvir. Get medical help right away if you take amiodarone with EPCLUSA and get any of the following symptoms: fainting or near-fainting, dizziness or lightheadedness, not feeling well, weakness, extreme tiredness, shortness of breath, chest pains, confusion, or memory problems.

The most common side effects of EPCLUSA include headache and tiredness. Tell your healthcare provider if you have any side effect that bothers you or does not go away.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

What is EPCLUSA?

EPCLUSA is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C genotype 1, 2, 3, 4, 5, or 6 infection with or without cirrhosis (compensated). In those with advanced cirrhosis (decompensated), EPCLUSA is used with ribavirin.

Please see Important Facts about EPCLUSA including Important Warning.

EPCLUSA, the EPCLUSA logo, SUPPORT PATH, the SUPPORT PATH logo, GILEAD and the GILEAD logo are trademarks of Gilead Sciences, Inc., or its related companies. All other trademarks referenced herein are the property of their respective owners.
The content on this site is intended for US residents only. Patient images are actor portrayals unless otherwise noted.

©2019 Gilead Sciences, Inc. All rights reserved. EPCC0397 07/19

Tap for Use and Important Safety Information about EPCLUSA including Important Warning on hepatitis B reactivation.